Citations

Citations to this article as recorded by  

• Precision oncology promise in the management of pancreatic acinar cell carcinoma
  Suriya Baskar, Rishi R. Patel, Matthew T. Gao, Brandon E. Rose, Sawyer Bawek, Deepak Vadehra, Timothy J. Brown, Nicholas J. Hornstein, Udhayvir S. Grewal
  European Journal of Cancer.2026; 234: 116223.     CrossRef
• Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation
  Benjamin Koh, Subotheni Thavaneswaran, Frank Lin, John Grady, Meghana Maddula, Koroush S. Haghighi, Maya Kansara, Min Li Huang, Mandy L. Ballinger, John Simes, David M. Thomas, David Goldstein
  JCO Precision Oncology.2026;[Epub]     CrossRef
• Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities
  Noor Farhoud, Raed Moh’d Taiseer Al-Rajabi, Joaquina Celebre Baranda, Haoran Li, Wei Zhang, Ravi Kumar Paluri, Ashish Manne, Prasad Dandawate, Weijing Sun, Anup Kasi
  Cancers.2026; 18(14): 2315.     CrossRef
• Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma
  Alex B. Blair, Shannon N. Radomski, Joanne Chou, Mengyuan Liu, Thomas Clark Howell, Wungki Park, Eileen M. O’Reilly, Lei Zheng, Vinod P. Balachandran, Alice C. Wei, T. Peter Kingham, Michael I. D’Angelica, Jeffrey Drebin, Sabino Zani, Dan G. Blazer, Richa
  Annals of Surgical Oncology.2025; 32(3): 1869.     CrossRef
• Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
  Cody Eslinger, Bobak Seddighzadeh, Claire Yee, Zaid Elsabbagh, Rish Pai, Chris Hartley, Jason Starr, Tanios Bekaii-Saab, Thorvardur R. Halfdanarson, Mohamad Bassam Sonbol
  JCO Precision Oncology.2025;[Epub]     CrossRef
• Pediatric pancreatic acinar cell carcinoma with a non-canonical BRAF-KMT2C fusion and a classic SND1-BRAF fusion: a case report and literature review
  Yaqin Wang, Jiasi Zhang, Dimin Nie, Ai Zhang, Qun Hu, Aiguo Liu
  BMC Pediatrics.2025;[Epub]     CrossRef
• The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines
  Kilian Trin, Cynthia Dalleau, Simone Mathoulin-Pelissier, Christophe Le Tourneau, Derek Dinart, Carine Bellera
  Current Oncology Reports.2025; 27(5): 516.     CrossRef
• Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study
  Abdul Qahar Khan Yasinzai, Asif Iqbal, Diego Olavarria-Bernal, Kalyani Ballur, Agha Wali, Shalini Ballur, Bisma Tareen, Marjan Khan, Hritvik Jain, Israr Khan, Nooran Fadhil, Amir Humza Sohail, Asad Ullah
  Journal of Gastrointestinal Cancer.2025;[Epub]     CrossRef
• Pancreatic panniculitis associated with presumed advanced pancreatic tumor: A case report and literature review
  Dunya Yang, Shouyue Chen, Xiaoyu Zhang, Xiangwu Lin, Shaoqin Lin, Qunxiang Chen, Zongjing Zhang, Jie Li, Xi Chen
  Pathology - Research and Practice.2025; 275: 156214.     CrossRef
• Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment
  Kenji Ikezawa, Makiko Urabe, Yugo Kai, Ryoji Takada, Hirofumi Akita, Shigenori Nagata, Kazuyoshi Ohkawa
  Japanese Journal of Clinical Oncology.2024; 54(3): 271.     CrossRef
• Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma
  Katsuhito Teramatsu, Nao Fujimori, Masatoshi Murakami, Sho Yasumori, Kazuhide Matsumoto, Kohei Nakata, Masafumi Nakamura, Yutaka Koga, Yoshinao Oda, Yoshihiro Ogawa
  Clinical Journal of Gastroenterology.2024; 17(4): 776.     CrossRef
• Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma
  Valeria Merz, Francesca Maines, Stefano Marcucci, Chiara Sartori, Michela Frisinghelli, Chiara Trentin, Dzenete Kadrija, Francesco Giuseppe Carbone, Andrea Michielan, Armando Gabbrielli, Davide Melisi, Mattia Barbareschi, Alberto Brolese, Orazio Caffo
  Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
• A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
  Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Ângelo Borsarelli Carvalho de Brito, Arthur Conelian Gentilli
  Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
• A case of unresectable ectopic acinar cell carcinoma developed in the portal vein in complete response to FOLFIRINOX therapy
  Shinnosuke Nakayama, Akihisa Fukuda, Tadayuki Kou, Manabu Muto, Hiroshi Seno
  Clinical Journal of Gastroenterology.2023; 16(4): 610.     CrossRef
• New treatment insights into pancreatic acinar cell carcinoma: case report and literature review
  Fangrui Zhao, Dashuai Yang, Tangpeng Xu, Jiahui He, Jin Guo, Xiangpan Li
  Frontiers in Oncology.2023;[Epub]     CrossRef
• A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX
  Shuhei Yamada, Haruka Motegi, Yoshiki Kurihara, Tomonori Shimbo, Isao Kikuchi, Toshiki Wakabayashi, Tsutomu Sato
  Surgical Case Reports.2023;[Epub]     CrossRef
• A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
  Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi
  Current Oncology.2023; 30(11): 9587.     CrossRef
• Progressive nodule-like lesions on bilateral lower limbs
  FA Yang, KS Cheng, JW Chou
  Journal of Postgraduate Medicine.2023; 69(1): 50.     CrossRef
• Mixed pancreatic acinar cell-ductal adenocarcinoma: Complexities in diagnosis and treatment
  Abdullah Nasser, Catherine L. Forse, Cynthia Walsh, Terence Moyana, Rakesh Goel
  Current Problems in Cancer: Case Reports.2022; 5: 100144.     CrossRef
• Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature
  Jian-Ying Xu, Wen-Long Guan, Shi-Xun Lu, Xiao-Li Wei, Wen-Jie Shi, Chao Ren, Yu-Hong Li, Sheng-Ping Li, Miao-Zhen Qiu, Feng-Hua Wang
  Clinical Medicine Insights: Oncology.2022;[Epub]     CrossRef
• Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report
  Sunao Uemura, Hiromichi Maeda, Nobuhisa Tanioka, Sachi Yamaguchi, Masaya Munekage, Hiroyuki Kitagawa, Tsutomu Namikawa, Shota Yamamoto, Takuhiro Kohsaki, Mitsuko Iguchi, Kazushige Uchida, Kazuhiro Hanazaki
  Cancer Reports.2022;[Epub]     CrossRef
• Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis
  Margaux Lelong, Jean‐Luc Raoul, Yann Touchefeu, Jean‐Marie Berthelot, Paul Arnolfo, Tamara Matysiak‐Budnik, Hélène Senellart
  Clinical Case Reports.2022;[Epub]     CrossRef
• Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma
  Hideaki Takahashi, Masafumi Ikeda, Satoshi Shiba, Hiroshi Imaoka, Akiko Todaka, Kazuhiko Shioji, Kei Yane, Yasushi Kojima, Satoshi Kobayashi, Akinori Asagi, Masato Ozaka, Ryoji Takada, Yoshikuni Nagashio, Shigeru Horiguchi, Akiyoshi Kasuga, Eiichiro Suzuk
  Pancreas.2021; 50(1): 77.     CrossRef
• Efficacy of chemotherapy combined with toripalimab in PD-L1–positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report
  Huanji Xu, Xin Wang, Sheng Zhou, Qiancheng Hu, Dan Cao
  Tumori Journal.2021; 107(6): NP24.     CrossRef
• Metastatic Acinar Cell Carcinoma of the Pancreas
  Elena Busch, Wiebke Werft, Nina Bougatf, Thilo Hackert, Dirk Jäger, Christoph Springfeld, Anne Katrin Berger
  Pancreas.2021; 50(3): 300.     CrossRef
• Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomes
  Vishwajith Sridharan, Mari Mino-Kenudson, James M. Cleary, Osama E. Rahma, Kimberly Perez, Jeffrey W. Clark, Thomas E. Clancy, Douglas A. Rubinson, Lipika Goyal, Fateh Bazerbachi, Kavel H. Visrodia, Motaz Qadan, Aparna Parikh, Cristina R. Ferrone, Brenna
  Pancreatology.2021; 21(6): 1119.     CrossRef
• Down‐regulation of metabolic pathways could offset the poor prognosis conferred by co‐existent diabetes mellitus in pancreatic (head) adenocarcinoma
  Nilesh Gardi, Madhura Ketkar, Ross A. McKinnon, Stephen J. Pandol, Shilpee Dutt, Savio G. Barreto
  ANZ Journal of Surgery.2021; 91(11): 2466.     CrossRef
• Pathological complete response in a patient with metastatic pancreatic acinar cell carcinoma who received a chemotherapy regimen containing cisplatin and irinotecan
  Hiromitsu Maehira, Hiroya Iida, Haruki Mori, Nobuhito Nitta, Aya Tokuda, Katsushi Takebayashi, Sachiko Kaida, Toru Miyake, Akiko Matsubara, Masaji Tani
  Clinical Journal of Gastroenterology.2021; 14(6): 1772.     CrossRef
• Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group
  Ekaterina Petrova, Joachim Wellner, Anne K. Nording, Rüdiger Braun, Kim C. Honselmann, Louisa Bolm, Richard Hummel, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Kees Kleihues van Tol, Sylvia Timme-Bronsert, Peter Bronsert, Sergey Zemskov, Tobias Keck,
  Cancers.2021; 13(23): 6121.     CrossRef
• The Unusual Suspects of the Pancreas—Understanding Pancreatic Acinar Cell Carcinomas and Adenomas
  Andreas Minh Luu, Tim Fahlbusch, Johanna Munding, Waldemar Uhl, Chris Braumann
  Journal of Gastrointestinal Cancer.2020; 51(1): 172.     CrossRef
• Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report
  Mariacristina Di Marco, Riccardo Carloni, Stefania De Lorenzo, Elisa Grassi, Andrea Palloni, Francesca Formica, Stefano Brocchi, Daria Maria Filippini, Rita Golfieri, Giovanni Brandi
  World Journal of Clinical Cases.2020; 8(7): 1241.     CrossRef
• Robot-assisted combined pancreatectomy/hepatectomy for metastatic pancreatic acinar cell carcinoma: case report and review of the literature
  Anthony Michael Villano, Dany Barrak, Anish Jain, Erin Meslar, Pejman Radkani, Walid Chalhoub, Nadim Haddad, Emily Winslow, Thomas Fishbein, Jason Hawksworth
  Clinical Journal of Gastroenterology.2020; 13(5): 973.     CrossRef
• Patients With Acinar Cell Carcinoma of the Pancreas After 2005
  Yuan Zong, Changsong Qi, Zhi Peng, Lin Shen, Jun Zhou
  Pancreas.2020; 49(6): 781.     CrossRef
• One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches
  Monica Niger, Michele Prisciandaro, Maria Antista, Melissa Anna Teresa Monica, Laura Cattaneo, Natalie Prinzi, Sara Manglaviti, Federico Nichetti, Marta Brambilla, Martina Torchio, Francesca Corti, Sara Pusceddu, Jorgelina Coppa, Vincenzo Mazzaferro, Fili
  World Journal of Gastrointestinal Oncology.2020; 12(8): 833.     CrossRef
• Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinoma
  Elena Busch, Simon Kreutzfeldt, Abbas Agaimy, Gunhild Mechtersheimer, Peter Horak, Benedikt Brors, Barbara Hutter, Martina Fröhlich, Sebastian Uhrig, Philipp Mayer, Evelin Schröck, Albrecht Stenzinger, Hanno Glimm, Dirk Jäger, Christoph Springfeld, Stefan
  Molecular Case Studies.2020; 6(4): a005553.     CrossRef
• Pancreatic panniculitis and elevated serum lipase in metastasized acinar cell carcinoma of the pancreas: A case report and review of literature
  Rainer Christoph Miksch, Tobias S Schiergens, Maximilian Weniger, Matthias Ilmer, Philipp M Kazmierczak, Markus O Guba, Martin K Angele, Jens Werner, Jan G D'Haese
  World Journal of Clinical Cases.2020; 8(21): 5304.     CrossRef
• The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study
  Nie Duorui, Bin Shi, Tao Zhang, Chuyao Chen, Chongkai Fang, Zhijun Yue, Peng Wu, Zhiming Wu, Xuewu Huang, Meng Li, Girijesh Kumar Patel
  PLOS ONE.2020; 15(12): e0243164.     CrossRef
• Pancreatic acinar cell carcinoma diagnosed by BCL10 staining: A case report
  Kei YAMANE, Takayuki ANAZAWA, Toshihiko MASUI, Kazuyuki NAGAI, Seiichiro TADA, Kenta INOGUCHI, Kenzo NAKANO, Yuichiro UCHIDA, Akitada YOGO, Kyouichi TAKAORI, Shinji UEMOTO
  Suizo.2019; 34(1): 46.     CrossRef
• Prognostic Factors of Acinar Cell Carcinomas
  Axel Egal, Jérôme Cros, Magali Svrcek, Laurence Chiche, Geneviève Belleannee, Flora Poizat, Lionel Jouffret, Frédérique Maire, Louis de Mestier, Pascal Hammel
  Pancreas.2019; 48(10): 1393.     CrossRef
• EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma
  Corentin Richard, Julie Niogret, Romain Boidot, Francois Ghiringhelli
  World Journal of Gastrointestinal Oncology.2018; 10(4): 103.     CrossRef
• Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors
  Oronzo Brunetti, Giuseppe Aprile, Paolo Marchetti, Enrico Vasile, Andrea Casadei Gardini, Mario Scartozzi, Sandro Barni, Sara Delfanti, Fernando De Vita, Francesco Di Costanzo, Michele Milella, Chiara Alessandra Cella, Rossana Berardi, Ivana Cataldo, Aldo
  Pancreas.2018; 47(6): 759.     CrossRef
• Pancreatic acinar cell carcinoma—case report and literature review
  Zhang Xing-mao, Zhang Hong-juan, Li Qing, He Qiang
  BMC Cancer.2018;[Epub]     CrossRef
• Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma
  Minami Hashimoto, Takuto Hikichi, Tomohiro Suzuki, Mayumi Tai, Osamu Ichii, Nobuo Matsuhashi, Eisaku Kita, Shintaro Takahashi, Yoshinori Okubo, Hando Hakozaki, Yutaka Ejiri, Hiromasa Ohira
  Clinical Journal of Gastroenterology.2017; 10(6): 564.     CrossRef